While in the CGGA dataset, we found that age (>60 years), WHO grade IV, IDH 1/2 wild-type, high GSDMD and GSDME expression could be used independently to predict the prognosis of gliomas patients (Table 2). The gene discussed is GSDMD; the disease is central nervous system cancer.